Medicine
from24/7 Wall St.
1 week agoNovo Nordisk Roars Back: 6 Catalysts Driving the Pharma's Path to Dominance
Novo Nordisk regained momentum in the GLP-1 market after competition and shortages, driven by strategic wins, resolved shortages, and expanded drug indications, boosting its stock.